VIVE — Viveve Medical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.28m
- $6.43m
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq
Brief: Viveve Announces Completion Of U.S. Pursuit Trial For Female Stress Urinary Incontinence
Brief: Viveve Medical Receives Notice Of Delisting From Nasdaq
Brief: Viveve Announces Issuance Of Second U.S. Method Patent For Treating Female Stress Urinary Incontinence
Brief: Viveve Medical Inc Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Viveve Medical Inc Reports Quarterly Loss Per Share Of $0.59 - Filing
Viveve Medical Inc reports results for the quarter ended in September - Earnings Summary
Viveve Medical Inc expected to post a loss of 66 cents a share - Earnings Preview
Brief: Viveve Announces Notice Of Allowance For Second U.S. Method Patent For Treating Female Stress Urinary Incontinence
Brief: Viveve Rebranding Initiative Focusing On Treatment Of Female Stress Urinary Incontinence In Anticipation Of U.S. Pivotal Pursuit Trial Readout
Viveve Medical Inc reports results for the quarter ended in June - Earnings Summary
Viveve Medical Inc expected to post a loss of 67 cents a share - Earnings Preview
Viveve Medical Inc reports results for the quarter ended in March - Earnings Summary
Viveve Medical Inc expected to post a loss of 57 cents a share - Earnings Preview
Viveve Medical Inc reports results for the quarter ended in December - Earnings Summary
Viveve Medical Inc expected to post a loss of 59 cents a share - Earnings Preview